OHB's Valuation Puzzle: Record Orders and a Fortified Balance Sheet, Yet the Shares Keep Sliding
Published on 08/08/2026 at 18:31 | Redaktion boerse-global.de
The disconnect between OHB SE's operational trajectory and its stock market performance has rarely been starker. The Bremen-based space and defence group just sealed the largest contract in its corporate history, posted double-digit profit growth, and nearly doubled its equity ratio — and yet the shares closed Friday at €233.50, roughly 22% below the €300 price at which investors snapped up new stock just weeks earlier.
A Balance Sheet Transformed in One Quarter
The equity story has arguably never looked stronger. Following the capital increase completed in June — which raised €484 million through the issuance of 1,613,023 new shares — OHB's equity ratio jumped from 27.5% at the end of 2025 to 43.3% by mid-2026. The balance sheet total expanded 35% to €2,113.5 million. The ownership structure remains unchanged: the Fuchs family retains its majority at 60.3%, with KKR's Orchid Lux HoldCo and free float each holding 19.7%.
That financial firepower matters because the company now carries a record order backlog of €3.3 billion — a substantial chunk of its €4.92 billion market capitalisation. The question investors are wrestling with is whether OHB can work through that volume profitably, or whether margin pressure and further dilution lurk as production scales up.
Half-Year Numbers Tell a Growth Story
The interim figures released Thursday paint a picture of a company delivering on its promises. Revenue climbed 11% to €627.9 million, up from €563.5 million in the prior-year period. Adjusted EBITDA rose 31% to €60.4 million, while adjusted EBIT jumped 46% to €38.9 million. The order book grew to €3,304 million from €3,067 million a year earlier.
Should investors sell immediately? Or is it worth buying OHB SE?
Management reaffirmed its full-year guidance of €1.4 billion in total output at an adjusted EBITDA margin between 10.5% and 11%, and reiterated the medium-term ambition of pushing total output beyond €4 billion with a margin around 13%.
IRIS² and a Pipeline of New Mandates
The headline event came on 6 August, when the EU Commission signed the contract with the SpaceRISE consortium for the IRIS² satellite constellation — expanded to 348 satellites, with OHB playing a central role in development and manufacturing. The first launches are scheduled for 2029, which means significant capital requirements before meaningful revenue from the project begins to flow.
The mandate pipeline extends well beyond IRIS². At the end of July, the Italian space agency ASI awarded OHB Italia the contract for the PRISMA Second Generation Earth observation mission, with launch targeted for late 2031. The company is also collaborating with MDA Space on autonomous landing technology for the Argonaut lunar mission. In mid-July, Defence Minister Boris Pistorius visited the Bremen site, where OHB and the European Spaceport Company presented plans to expand rocket launch capabilities. Meanwhile, the joint venture with Rheinmetall, established in June and already cleared by the Federal Cartel Office, is reportedly targeting a multi-billion-euro Bundeswehr contract for a military satellite network.
The Technical Picture: A Steep Correction
The share price tells a different story. The stock stands 66% below its 52-week high of €688 from May, and has fallen 16.61% over the past 30 days. It trades roughly 24% below its 50-day moving average and hovers just under the 200-day line at €247.60 — a level that could prove pivotal. The RSI of 38.4 suggests the stock is neither oversold nor strongly positioned. Annualised volatility sits at a hefty 57.64%.
Analysts, however, see value at current levels. Deutsche Bank initiated coverage on 5 August with a "Buy" rating, and several other research houses launched coverage the same day with price targets ranging from €250 to €360 — all above Friday's close.
OHB SE at a turning point? This analysis reveals what investors need to know now.
A Correction or a Reckoning?
The market's reaction may reflect a classic post-rally pattern. After a 250.60% gain over twelve months and a 99.57% advance since the start of the year, profit-taking on good news rather than follow-through buying is hardly unusual. The dilution from the capital increase likely amplified the effect. The broader transaction totalled €900 million, including a share sale by KKR, with OHB receiving approximately €482 million gross from the new share issuance.
The near-term direction may hinge on the 200-day line. A sustained move back above €247.60 could open the path toward the €300 placement level. The next catalyst would be concrete production plans for the additional 66 satellites in the IRIS² expansion — evidence that OHB can execute efficiently at scale would go some way toward easing margin concerns. Without such clarity, the shares may remain stuck in a technical downtrend, caught between operational momentum and market scepticism.
Ad
OHB SE Stock: New Analysis - 8 August
Fresh OHB SE information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
